Sales 2024 * | 120M 9.56B | Sales 2025 * | 130M 10.36B | Capitalization | 91.32M 7.27B |
---|---|---|---|---|---|
Net income 2024 * | -16M -1.27B | Net income 2025 * | 1M 79.62M | EV / Sales 2024 * | 0.76 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.7 x |
P/E ratio 2024 * |
-6.18
x | P/E ratio 2025 * |
210
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.77% |
Latest transcript on Depomed Inc
Managers | Title | Age | Since |
---|---|---|---|
Heather Mason
CEO | Chief Executive Officer | 63 | 31/01/19 |
Ajay Patel
DFI | Director of Finance/CFO | 40 | 30/06/19 |
Howard Franklin
CTO | Chief Tech/Sci/R&D Officer | - | 05/03/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Staple
CHM | Chairman | 72 | 31/10/03 |
James Tyree
BRD | Director/Board Member | 71 | 30/09/16 |
William McKee
BRD | Director/Board Member | 62 | 28/02/17 |
1st Jan change | Capi. | |
---|---|---|
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |